These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1893174)

  • 1. [Change in inotropic and chronotropic function of the heart and resistance of the coronary vessels during combined use of Ca2+ antagonists].
    Tkachenko BI; Kostko SZ; Katsenovich RA; Stepanova TG; Shil'kurt BL
    Biull Eksp Biol Med; 1991 Jun; 111(6):584-6. PubMed ID: 1893174
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium channel blockers: rationale for their clinical use.
    Conti CR
    J Fla Med Assoc; 1981 Nov; 68(11):883-6. PubMed ID: 6120992
    [No Abstract]   [Full Text] [Related]  

  • 3. [Various aspects of the effects of beta adrenergic receptor blockaders, stimulants and calcium antagonists on the cardiovascular system].
    Katsenovich RA; Kostko SZ
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(1):57-63. PubMed ID: 4005055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
    Simon R
    Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nisoldipine on coronary resistance, contractility and oxygen consumption of the isolated blood-perfused canine left ventricle.
    Schipke JD; Burkhoff D; Alexander J; Schaefer J; Sagawa K
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1000-4. PubMed ID: 3252017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fundamental cardiac and vascular effects of Ca++-antagonistic coronary drugs].
    Fleckenstein A
    Med Klin; 1975 Oct; 70(42):1665-74. PubMed ID: 1102892
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of tetrandrine and verapamil on contractility and oxygen consumption of the heart muscles].
    Yao WX; Xia GJ; Fang DC; Jiang MX
    Zhongguo Yao Li Xue Bao; 1984 Jun; 5(2):97-100. PubMed ID: 6235719
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute coronary hemodynamic effects of equihypotensive doses of nisoldipine and diltiazem.
    Suryapranata H; Serruys PW; Soward AL; Planellas J; Vanhaleweyk G; Hugenholtz PG
    Aust N Z J Med; 1985 Dec; 15(6):685-90. PubMed ID: 3869435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.
    Nishimura K; Miyawaki N; Yamauchi H; Iso T
    Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of the antianginal action of oxyfedrine].
    Chichkanov GG; Chumburidze VB
    Farmakol Toksikol; 1977; 40(3):302-6. PubMed ID: 20326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temperature dependence of calcium antagonist action.
    Piper HM; Hütter JF; Spieckermann PG
    Arzneimittelforschung; 1985; 35(10):1495-8. PubMed ID: 4074403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two calcium antagonists, verapamil and fendiline, in an experimental model of myocardial ischaemia mimicking classical angina on effort.
    Csik V; Szekeres L; Udvary E
    Br J Pharmacol; 1983 May; 79(1):37-43. PubMed ID: 6871551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
    Hamm CW; Opie LH
    Circ Res; 1983 Feb; 52(2 Pt 2):I129-38. PubMed ID: 6831647
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of M-nifedipine on contractile responses in isolated atria and coronary vessels: a comparison with nifedipine].
    Rao MR; Liang MD; Liu F; Shen XH; Zou X
    Yao Xue Xue Bao; 1986 May; 21(5):321-5. PubMed ID: 3776539
    [No Abstract]   [Full Text] [Related]  

  • 17. Negative inotropic effect of verapamil, nifedipine and prenylamine and its reversal by calcium or isoproterenol.
    Mattiazzi AR; Garay A
    Arch Int Physiol Biochim; 1983 Sep; 91(3):133-44. PubMed ID: 6198983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Negative inotropic effects and constipation caused by verapamil?].
    Joost HG; Müller A
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S5. PubMed ID: 10818993
    [No Abstract]   [Full Text] [Related]  

  • 19. [Different sites of action of diltiazem, nifedipine and verapamil on the myocardium and aortic and coronary smooth muscles].
    Raddino R; Poli E; Manca C; Ceconi C; Ferrari R
    Cardiologia; 1986 Jan; 31(1):47-53. PubMed ID: 3742515
    [No Abstract]   [Full Text] [Related]  

  • 20. [Myocardial cellular mechanism of action of calcium antagonists].
    Ferrari R; Boffa GM; Ciampalini G; Ceconi C
    Cardiologia; 1985 Feb; 30(2):77-89. PubMed ID: 3905004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.